Debiopharm Innovation Fund — 2023 Investments
4 investments dated 2023 · listed companies and verified rows first · show all
Altis provides independent, IC-grade investment diligence and market research on private companies from Seed to Series D+, working outside-in without access to management or data rooms.
AI & Machine LearningData & InfrastructureFintech
Co-investorsPrimary Venture PartnersGalapagos Capital
Altis Labs provides a web-based platform that applies AI models to medical imaging data to generate reproducible predictions and quantifications for clinical trials.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesToronto, CA
Felix Baldauf-Lenschen(Founder & CEO)inJohn(CTO)
Co-investorsCreative Destruction Lab (CDL)FusionOrbiMedBenchstrength Partners
Genialis is a precision oncology company that applies data analysis to help drug developers understand mechanisms of action, resistance, and patient stratification for cancer therapies.
AI & Machine LearningBiotechDigital HealthMedical DevicesBoston, US
Miha Štajdohar(Executive Officer, Director)inRafael Rosengarten(Chief Executive Officer and Co-founder)inLuka Ausec(Executive Officer)inHamzeh Abdul-Hadi(Director)Tjasa Krisper Kutin(Executive Officer)
Co-investorsAngelini VenturesTaiwania CapitalFirst Star VenturesScaleX Venturesredalpine
Spaya is an AI-powered retrosynthesis platform that identifies synthetic routes to target compounds by converting them into commercially available starting materials.
AI & Machine LearningBiotechDeep TechMedical DevicesParis, FR
Yann(Co-founder and CEO)Quentin(Co-founder and CSO)Nicolas(Co-founder and CTO)
Co-investorsM VenturesOmnes Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.